Trump’s Big‑Weed Gamble

By moving marijuana to Schedule III, the administration would normalize national cannabis brands (tax deductibility, advertising, delivery), boosting use and exacerbating young men’s detachment from work and marriage. Post-legalization data (e.g., tripled post-accident positive tests) and high cannabis-use disorder rates suggest social costs despite investor upside. — Connects drug policy design to male malaise, family formation, and corporate capture—shaping debates over public health, labor markets, and the ethics of monetizing intoxication under a 'wellness' banner.